US-EU Index Rebalances / Quantitative Researcher, ORTEX

Dimitris Ioannidis

Index Rebalance professional of US, EU and Global Indices. Specialized in shareholder structure and index free float calculation, SPACs, quarterly rebalance predictions of US-EU indices and cross-index implications of corporate actions such as M&A's, Spin-offs and IPOs.

All forecasts and calculations are estimates derived from a combination of public sources considered reliable. These sources include, but are not limited to, exchange and regulatory filings, company announcements, and ETFs. While best efforts are made to maximize accuracy, estimates and predictions are subject to uncertainty.

No index data are used.

US-EU Index Rebalances / Quantitative Researcher

Super Micro Computer (SMCI): Investigation Clears Fraud Claims, But Is the Stock Still a Risk?

Global Financial Data and Analytics Platform

ORTEX

ORTEX is a global financial data and analytics platform providing real-time securities lending and short interest data, index rebalance data, holdings and insider transactions, trading signals, corporate actions and news,  stock machine learning and factor scores and other analytics. The majority of the data are downloadable and accessible through APIs.

Index Rebalance

<ul>
<li>The company filed the required SEC filings right on the deadline of 25 February 2025, thus has avoided a Nasdaq delisting and consequently a deletion from s&amp;p500 and other indices.</li>
<li>The security continues to be a contender for Nasdaq-100 inclusion at the December 2025 annual review.</li>
<li>The stock is up ~21.7% pre-market following the SEC filings.</li>
</ul>


The company filed the required SEC filings right on the deadline of 25 February 2025, thus has avoided a Nasdaq delisting and consequently a deletion from s&amp;p500 and other indices.
The security continues to be a contender for Nasdaq-100 inclusion at the December 2025 annual review.
The stock is up ~21.7% pre-market following the SEC filings.


슈퍼마이크로컴퓨터(SMCI US): 나스닥 상장폐지 회피 및 나스닥100 편입 목표